(Q37325790)

English

Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation (English)

1 reference

Europe PubMed Central

19 August 2017

lung transplant

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

invasive fungal infections

1 reference

based on heuristic

inferred from title

author name string

J M Borro

1

1 reference

Europe PubMed Central

19 August 2017

A Solé

2

1 reference

Europe PubMed Central

19 August 2017

M de la Torre

3

1 reference

Europe PubMed Central

19 August 2017

A Pastor

4

1 reference

Europe PubMed Central

19 August 2017

R Fernandez

5

1 reference

Europe PubMed Central

19 August 2017

A Saura

6

1 reference

Europe PubMed Central

19 August 2017

M Delgado

7

1 reference

Europe PubMed Central

19 August 2017

E Monte

8

1 reference

Europe PubMed Central

19 August 2017

D Gonzalez

9

1 reference

Europe PubMed Central

19 August 2017

language of work or name

0 references

publication date

1 November 2008

1 reference

Europe PubMed Central

19 August 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

19 August 2017

40

1 reference

Europe PubMed Central

19 August 2017

9

1 reference

Europe PubMed Central

19 August 2017

3090-3093

1 reference

Europe PubMed Central

19 August 2017

Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Aspergillus infections in lung transplant recipients: risk factors and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Current approaches to diagnosis and treatment of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Pulmonary complications of solid organ and hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Fungal infections in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Antifungal prophylaxis in transplant recipients: where do we go from here?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Voriconazole Prophylaxis in Lung Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Safety of aerosolized amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Safety of aerosolized amphotericin B lipid complex in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.020

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2008.09.020

1 reference

Europe PubMed Central

19 August 2017

release_prpttzrwyjhbndaqqdapbmg6km

1 reference

https://api.fatcat.wiki/v0/release/prpttzrwyjhbndaqqdapbmg6km

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37325790&oldid=1844225395"